Cytek Biosciences Inc (CTKB)
Payables turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 89,347 | 83,589 | 63,062 | 48,806 | 41,129 |
Payables | US$ in thousands | — | — | — | — | — |
Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $89,347K ÷ $—K
= —
The payables turnover ratio for Cytek Biosciences Inc has been consistently reported as "—" for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. This indicates that the company's financial statements do not provide the necessary data to calculate the payables turnover ratio, which is typically used to assess how efficiently a business manages its accounts payable in relation to its purchases. It is important for Cytek Biosciences Inc to provide more detailed financial information in order to evaluate its payables turnover and overall liquidity management.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
Cytek Biosciences Inc
CTKB
—
Avantor Inc
AVTR
6.80
Bio-Rad Laboratories Inc
BIO
—
Bruker Corporation
BRKR
7.33
Illumina Inc
ILMN
6.84
Mettler-Toledo International Inc
MTD
7.17
Revvity Inc.
RVTY
8.32
Waters Corporation
WAT
26.41